Fulgenzi, Claudia A. M.
Talbot, Thomas
Murray, Sam M.
Silletta, Marianna
Vincenzi, Bruno
Cortellini, Alessio
Pinato, David J. http://orcid.org/0000-0002-3529-0103
Funding for this research was provided by:
Wellcome Trust (PS3416)
Article History
Accepted: 9 May 2021
First Online: 23 August 2021
Declarations
:
: Claudia A.M. Fulgenzi declares that she has no conflict of interest.Thomas Talbot declares that he has no conflict of interest.Sam M. Murray declares that he has no conflict of interest.Marianna Silletta declares that she has no conflict of interest.Bruno Vincenzi declares that he has no conflict of interest.Alessio Cortellini has received research funding from AstraZeneca, MSD, Bristol-Myers Squibb, Roche, Novartis, and Astellas.David J. Pinato has received research funding (paid to his institution) from Bristol-Myers Squibb and MSD; and has received compensation for service as a consultant from Bristol-Myers Squibb, Roche, Eisai, H3 Biomedicine, Da Volterra, MiNA Therapeutics, Falk Foundation, and ViiV Healthcare.